Advertisement

Infektionskrankheiten

  • Norbert Suttorp
  • Martin Mielke
  • Henning Breithaupt
  • Frank Bergmann
  • Ulrich Bienzle
  • Friedrich Grimminger
  • Jürgen Lohmeyer
  • Werner Seeger
  • Hans-Dieter Walmrath
  • Dirk Schürmann

Zusammenfassung

Infektionskrankheiten fallen durch ihre Übertragbarkeit, d. h. die Kontagiosität der von ihnen befallenen Patienten und die daraus folgende endemische oder epidemische Häufung gleichförmiger Krankheitsbilder auf. Nur wenige Krankheiten des Menschen haben eine so eindeutig definierte Ätiologie. Dennoch sollte die bahnbrechende Entdeckung der mikrobiellen Ursachen von Infektionskrankheiten gegen Ende des vorletzten Jahrhunderts nicht zur Annahme führen, dass der Zusammenhang zwischen Erreger und Erkrankung monokausal sei. Erst das Zusammentreffen aus Exposition (gegenüber dem infektiösen Agens) und Disposition (des Wirtes) führt zur Infektion. Darüber hinaus ist Infektion nicht gleichbedeutend mit Krankheit.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Brodt HR, Helm EB, Kamps BS (2001) AIDS 2001. Diagnostik und Therapie. Steinhäuser, WuppertalGoogle Scholar
  2. Cook GC (ed) (1997) Manson’s tropical diseases. WB Saunders, LondonGoogle Scholar
  3. Deutsche Gesellschaft für Pädiatrische Infektiologie (DGPI) (1997) Handbuch Infektionen bei Kindern und Jugendlichen. Futuramed, MünchenGoogle Scholar
  4. Enders G (1991) Infektionen und Impfungen in der Schwangerschaft. Urban & Schwarzenberg, MünchenGoogle Scholar
  5. Mandell GL, Bennett JE, Dolin R (eds) (2000) Principles and practice of infectious diseases. Churchill Livingstone, LondonGoogle Scholar
  6. Milatovic D; Braveny I (1997) Infektionen. Praktische Hinweise zur antimikrobiellen Therapie und Diagnostik. MMV-Verlag, MünchenGoogle Scholar
  7. Mauch H, Lütticken R, Gatermann S (Hrsg) (lose Heftausgabe) MIQ-Qualitätsstandards in der mikrobiologisch-infektiologischen Diagnostik. Gustav Fischer, MünchenGoogle Scholar
  8. Barlow GD, Nathwani D (2000) Sequential antibiotic therapy. Curr Opin Infect Dis 13: 599–607PubMedGoogle Scholar
  9. Bodey GP (1995) Emerging antimicrobial-resistant pathogens in the immuncompromised host. Curr Opin Infect Dis 8: 411–414Google Scholar
  10. Bodmann KF (1996) Antimikrobielle Therapie. In: Schuster HP (Hrsg) Intensivtherapie bei Sepsis. Springer, Berlin Heidelberg New York Tokyo, S 55–70Google Scholar
  11. Breithaupt H (1998) Antibiotikatherapie schwerer nosokomialer Infektionen. Klinikarzt 27: 188–192Google Scholar
  12. Extermann M, Regamey C (1994) Empirical antibiotic treatment of sepsis in non-neutropenic patients: single agent or combination therapy. Infection 22: 15–37Google Scholar
  13. Gilbert DN, Moellning RC, Sande MA (eds) (2000) The Sanford Guide to Antimicrobial Therapy, 30th edn. Antimicrobial Therapy Inc, Main/VTGoogle Scholar
  14. Maschmeyer G, Link H, Hiddemann W u. a. (1994) Empirische antimikrobielle Therapie bei neutropenischen Patienten. Ergebnisse einer multizentrischen Studie der Arbeitsgruppe Infektionen in der Hämatologie der Paul-Ehrlich-Gesellschaft. Med Klin 89: 114–123Google Scholar
  15. Naher KG, Vogel F, Scholz H u. a. (1998) Rationaler Einsatz oraler Antibiotika in der Praxis. Chemother J 7: 16–26Google Scholar
  16. Simon C, Stille W (1999) Antibiotika-Therapie in Klinik und Praxis, 10. Aufl. Schattauer, Stuttgart New YorkGoogle Scholar
  17. Vogel F, Naber KG, Wacha H u. a. (1999) Parenterale Antibiotika bei Erwachsenen. Chemother J 8: 3–49Google Scholar
  18. Abraham E (2000) Coagulation abnormalities in acute lung injury and sepsis. Am J Respir Cell Mol Biol 22: 401–404PubMedGoogle Scholar
  19. Adal KA, Cockerell CI, Petri WA Jr (1994) Cat scratch disease, bacillary angiomatosis and other infections due to Rochalimaea. N Engl J Med 350: 1509Google Scholar
  20. Akerele T, Lightman S (1999) Current and novel agents for the treatment of cytomegalovirus retinitis. Drugs R D 2 (5): 289–297PubMedGoogle Scholar
  21. American Thoracic Society (1996) Hospital acquired pneumonia in adults: Diagnosis, assessment of severity, initial antimicrobial therapy, and preventive strategies. Am J Respir Crit Care Med 153: 1711–1725Google Scholar
  22. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR (2001) Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 29: 1303–1310Google Scholar
  23. Arbeitsgemeinschaft Peritonitis (PEG) (1983) Bakterielle Befunde bei verschiedenen Peritonitisformen. FAC 2 /3: 423–429Google Scholar
  24. Arbeitsgemeinschaft Wissenschaftliche Medizinische Fachgesellschaften (AWMF): Leitlinie zu Diagnostik und Therapie der Malaria. wwwawmf-leitlinien.deGoogle Scholar
  25. Ariza JF et al. (1992) Treatment of human brucellosis with doxycycline plus rifampine or doxycycline plus streptomycin: a randomized double blind study. Ann Intern Med 117: 25PubMedGoogle Scholar
  26. Bernard GR, Vincent JL, Laterre PF et al. (2001) Efficacy and safety of recombinat human activated protein C for severe sepsis. N Engl J Med 344: 699–709PubMedGoogle Scholar
  27. Bisno AL, Stevens DL (1996) Streptococcal infections of skin and soft tissues. N Engl J Med 334: 240–245PubMedGoogle Scholar
  28. Blake M, Sherer R (2000) Management of the adverse effects of antiretroviral therapy and medication adherence. Clin Infect Dis 30: S96–5116Google Scholar
  29. Blockmans D, Knockaert D, Maes A, de Caestecker J, Stroobants S, Bobbaers H, Mortelmans L (2001) Clinical value of [(18)F]fluoro-deoxyglucose positron emission tomography for patients with fever of unknown origin. Clin Infect Dis 32: 191PubMedGoogle Scholar
  30. Bohnen JMA (1998) Antibiotic therapy for abdominal infection. World J Surg 22: 152–157PubMedGoogle Scholar
  31. Bollaert PE, Charpentier C, Levy B, Debouverie M, Audibert G, Larcan A (1998) Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit Care Med 26: 645–650PubMedGoogle Scholar
  32. Bozzette S, Sattler F, Chiu Jet al. (1990) A controlled trial of early adjunctive treatment with corticosteroids for Pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323: 1451–1457PubMedGoogle Scholar
  33. Briegel J, Forst H, Haller M et al. (1999) Stress doses of hydrocortisone reverse hyperdynamic septic shock: A prospective, randomized, double-blind, single-center study. Crit Care Med 27: 723–732PubMedGoogle Scholar
  34. Brockmeyer NH, Salzberger B, Doerr HW, Marcus U, Brodt HR (2001) Antiretrovirale Therapie der HIV-Infektion. Dtsch Ärztebl 98: A175 - A181Google Scholar
  35. Brodt HR, Helm EB, Kamps BS (2000) AIDS 2000. Steinhäuser, Wuppertal-BeyenburgGoogle Scholar
  36. Buchbinder SP, Katz MH, Hessol NA, O’Malley PM, Holmberg SD (1994) Long-term HIV-1 infection without immunologic progression. AIDS 8 (8): 1123–1128Google Scholar
  37. Burchard GD (Hrsg) (1998) Erkrankungen bei Immigranten. Diagnostik, Therapie, Begutachtung. Gustav Fischer, StuttgartGoogle Scholar
  38. Carr A (2000) HIV protease inhibitor-related lipoatrophy syndrom. Clin Infect Dis S2: S135 - S142Google Scholar
  39. Centers for Disease Control and Prevention (1998) 1998 sexually transmitted disease treatment guidelines. MMWR 147: 28Google Scholar
  40. Chaisson R, Bishai W (1999) The management of pneumocystis carinii, toxoplasmosis, and HSV infections in patients with HIV disease. In: HIV clinical management, vol 7. Medscape, HillsboroGoogle Scholar
  41. Chapuis AG et al. (2000) Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo. Nat Med 6 (7): 762–768PubMedGoogle Scholar
  42. Chesney MA (2000) Factors affecting adherence to antiviral therapy. Clin Infect Dis 30: S171 - S176PubMedGoogle Scholar
  43. Cloyd MW, Chen JJ, Wang I (2000) How does HIV cause AIDS? The homing theory. Mol Med Today 6 (3): 108–111PubMedGoogle Scholar
  44. Cohen JI (2000) Epstein Barr Virus Infection. N Engl J Med 343: 481–492PubMedGoogle Scholar
  45. Collaborative Group on AIDS Incubation and HIV Survival including the CASCADE EU Concerted Action. Concerted Action on SeroConversion to AIDS and Death in Europe (2000) Time from HIV-1 seroconversion to AIDS and death before widespread use of highly-active antiretroviral therapy: a collaborative re-analysis. Lancet 355 (9210): 1131–1137Google Scholar
  46. Cook GC (ed) (1996) Manson’s tropical diseases. WB Saunders, LondonGoogle Scholar
  47. Cox NJ, Hughes JM (1999) New options for the prevention of influenza. N Engl J Med 342: 1387Google Scholar
  48. Cronin L, Cook DJ, Carlet J (1995) Corticosteroid treatment for sepsis: a critical appraisal and meta-analysis of the literature. Crit Care Med 23: 1430–1439PubMedGoogle Scholar
  49. Cunha BA (1996) Fever of unknown origin. Infect Dis Clin North Am 10: 111PubMedGoogle Scholar
  50. Dattwyler RJ et al. (1997) Ceftriaxone compared with doxycycline for the treatment of acute disseminated Lyme disease. N Engl J Med 337: 289PubMedGoogle Scholar
  51. Davey RT et al. (2000) Immunologic and virologic effects of subcutaneous interleukin 2 in combination with antiretroviral therapy: A randomized controlled trial. JAMA 284 (2): 183–189PubMedGoogle Scholar
  52. De Luca A, Giancola ML, Ammassari A et al. (2000) Cidofovir added to HAART improves virological and clinical outcome in AIDS-associated progressive multifocal leukoencephalopathy. AIDS 14: F117–121PubMedGoogle Scholar
  53. Dudley RA, Johansen KL, Brand R, Rennie DJ, Milstein A (2000) Selective referral to high-volume hospitals: estimating potentially avoidable deaths. JAMA 283 (9): 1159–1166PubMedGoogle Scholar
  54. Engels EA et al. (1999) Plasma HIV viral load in patients with hemophilia and late-stage HIV disease: A measure of current immune suppression. Ann Intern Med 131: 256–264PubMedGoogle Scholar
  55. Fishman JA, Rubin RH (1998) Infection in organ-transplant recipients. N Engl J Med 338: 1741PubMedGoogle Scholar
  56. Franz DR et al. (1997) Clinical recognition and management of patients exposed to biological warfare agents. JAMA 278: 5Google Scholar
  57. Freifeld A, Marchigiani D, Walsh T et al. (1999) A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy. N Engl J Med 341 (5): 305–311PubMedGoogle Scholar
  58. Gagnon S, Boota AM, Fischi MA (1990) Corticosteroids as adjunctive therapy for pneumocystis carinii pneumonia in the acquired immunodeficiency syndrome. N Engl J Med 323: 1440–1450Google Scholar
  59. Gerber JG (2000) Using pharmakokinetics to optimize antiretroviral drug-drug interactions in the treatment of human immunodeficiency virus infection. Clin Infect Dis 30: S123 - S129PubMedGoogle Scholar
  60. German-Austrian guidelines for antiretroviral therapy in HIV infection, June 1999 (2000) Eur J Med Res 5 (3): 129–138Google Scholar
  61. German-Austrian guidelines for HIV-therapy during pregnancy -status: May/June 1998 - common statement of the Deutsche AIDS-Gesellschaft (DAIG) and the Österreichische AIDS-Gesellschaft (ÖAG) (1999) Eur J Med Res. 4(1): 35–42Google Scholar
  62. Haring R (1993) Peritonitis. Thieme, StuttgartGoogle Scholar
  63. Harrigan PR, Côté HCF (2000) Clinical utility of testing human immunodeficiency virus for drug resistance. Clin Infect Dis 30: S117 - S122PubMedGoogle Scholar
  64. Harrington M, Carpenter CCJ (2000) Hit HIV-1 hart, but only when necessary. Lancet 355: 2147–2152PubMedGoogle Scholar
  65. Hau T, Obmann C, Wolmershauser A, Wacha H (Group of the Surgical Infection Society of Europe) (1995) Planned relaparotomy versus relaparotomy on demand in the treatment of intraabdominal infections. Arch Surg 130: 1193–1197PubMedGoogle Scholar
  66. Hirschmann JV (1997) Fever of unknown origin in adults. Clin Infect Dis 24: 291PubMedGoogle Scholar
  67. Hof H, Nichterlein T, Kretschmar M (1997) Management of Listeriosis. Clin Microbiol Rev 10: 345PubMedGoogle Scholar
  68. Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG (1992) CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections. Am J Infect Control 20: 271–274PubMedGoogle Scholar
  69. Hord CE (1995) Treatment of intraabdominal infections: worldwide clinical trials. Infect Dis Clin Pract 4: 17–25Google Scholar
  70. Hughes WT, Armstrong D, Bodey GP et al. (Infectious Diseases Society of America) (1997) 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Clin Infect Dis 25(3): 551–573Google Scholar
  71. Jolly PE, Weiss HL (2000) Neutralization and enhancement of HIV-1 infection by sera from HIV-1 infected individuals who progress to disease at different rates. Virology 273: 52–59PubMedGoogle Scholar
  72. Jouan M, Saves M, Tubiana R et al. (RESTIMOP study team) (2001) Discontinuation of maintenance therapy for cytomegalovirus retinitis in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 15(1): 23–31PubMedGoogle Scholar
  73. Kahn JO, Walker BD (1998) Acute human immunodeficiency virus type 1 infection. N Engl J Med 339: 33–40PubMedGoogle Scholar
  74. Kaplan EJ, Masur H, Holmes KK (2000) Prevention of opportunistic infections in persons infected with HIV CID 30 (Suppl 1)Google Scholar
  75. Knobloch J (Hrsg) (1996) Tropen-and Reisemedizin. Gustav Fischer, StuttgartGoogle Scholar
  76. Kolson DL, Gonzalez-Scarano F (2000) HIV and HIV dementia. J Clin Invest 106 (1): 11–13PubMedGoogle Scholar
  77. Korber B et al. (2000) Timing the ancestor of the HIV-1 pandemic strains. Science 288: 1789–1796PubMedGoogle Scholar
  78. Koup RA (2000) Immunopathogenesis of HIV Infection. Medscape, HillsboroGoogle Scholar
  79. Kujath P, Eckmann C (1998) Die nekrotisierende Fasziitis and schwere Weichteilinfektionen durch Gruppe-A-Streptokokken. Diagnose, Therapie and Prognose. Dtsch Ärztebi 95: B 347–352Google Scholar
  80. Kuntz P, Pieringer-Müller E, Hof H (1996) Infektionsgefahrdung durch Bissverletzungen. Dtsch Ärztebl 93: B 765–768Google Scholar
  81. Kuritzkes D (2000) HIV pathogenesis and viral markers. In: HIV clinical management. Medscape, HillsboroGoogle Scholar
  82. Kuritzkes D (2000) Viral pathogenesis: Update and clinical implications. Medscape, HillsboroGoogle Scholar
  83. Lang W, Löscher T (Hrsg) (2000) Tropenmedizin in Klinik and Praxis. Thieme, StuttgartGoogle Scholar
  84. Lederman MM, Valdez H (2000) Immune restoration with antiretroviral therapies: implications for clinical management. JA-MA 284 (2): 223–228Google Scholar
  85. Lefering R, Neugebauer EAM (1995) Steroid controversy in sepsis and septic shock: a meta.analysis. Grit Care Med 23: 1294–1303Google Scholar
  86. Levison ME, Bush LM (2000) Peritonitis and other intra-abdominal infections. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas and Bennett’s principles and practice of infectious diseases, 5th edn. Churchill Livingstone, Philadelphia, p 821–856Google Scholar
  87. Lopez Bernaldo de Quiros JC, Miro JM, Pena JM et al. (Grupo de Estudio del SIDA 04/98) (2001) A randomized trial of the discontinuation of primary and secondary prophylaxis against pneumocystis carinii pneumonia after highly active antiretroviral therapy in patients with HIV infection N Engl J Med 344(3): 159–167Google Scholar
  88. Mader JT, Calhoun J (2000) Osteomyelitis. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas and Bennett’s principles and practice of infectious diseases, 5th edn. Churchill Livingstone, Philadelphia, 1182–1200Google Scholar
  89. Mallal SA, John M, Moore CB, James IR, McKinnon EJ (2000) Contribution of nucleoside analogue reverse transcriptase inhibitors to subcutaneous fat wasting in patients with HIV infection. AIDS 14: 1309–1316PubMedGoogle Scholar
  90. Mocroft A et al. (2000) AIDS across Europe, 1994–98: the EuroSlDA study. Lancet 354: 291–296Google Scholar
  91. Montaner JS, Lawson LM, Levitt N (1990) Corticosteroids prevent early deterioration in patients with moderate severe pneumocystis carinii pneumonia and the acquired immunodeficiency syndrome. Ann Intern Med 113: 14–20PubMedGoogle Scholar
  92. Moyle GJ (2000) Considerations in the choice of protease inhibitor-sparing regimens in initial therapy for HIV-1 infection. Curr Opin Infect Dis 13: 19–25PubMedGoogle Scholar
  93. Mussini C et al. (2000) Discontinuation of primary prophylaxis for pneumocystis carinii pneumonia and toxoplasmic encephalitis in human immunodeficiency virus type I-infected patients: the changes in opportunistic prophylaxis study. J Infect Dis 181 (5): 1635–1642PubMedGoogle Scholar
  94. Nadal D, Zbinden R (1996) Erkrankungen durch Bartonellen. Internist 37: 890–894PubMedGoogle Scholar
  95. Norden C, Gillespie WJ, Nade S (eds) (1994) Infections in bones and joints. Blackwell Scientific Publications, BostonGoogle Scholar
  96. Norman C (2000) HIV and Africa’s future. Science 288 (5474): 2149PubMedGoogle Scholar
  97. O’Brien WA, Hartigan PM, Daar ES, Simberkoff MS, Hamilton JD (VA Cooperative Study Group on AIDS) (1997) Changes in plasma HIV RNA levels and CD4’ lymphocyte counts predict both response to antiretroviral therapy and therapeutic failure. Ann Intern Med 126 (12): 939–945PubMedGoogle Scholar
  98. Ozer H, Armitage JO, Bennett CL et al. (American Society of Clinical Oncology Growth Factors Expert Panel) (2000) 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. J Clin Oncol 18(20): 3558–3585PubMedGoogle Scholar
  99. Paterson DL et al. (2000) Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 133 (1): 21–30PubMedGoogle Scholar
  100. Petersdorf RC, Beeson PB (1996) Fever of unexplained origin. Medicine 40: 1Google Scholar
  101. Pizzo PA (1999) Fever in immunocompromised patients. N Engl J Med 341 (12): 893–900PubMedGoogle Scholar
  102. Podbielski A, Rozdzinski E, Wiedeck H, Lütticken R (1998) Gruppe-A-Streptokokken und die nekrotisierende Fasziitis. Dtsch Arztebl 95: B 353–359Google Scholar
  103. Powderly WG (1999) Fungal infections: Diagnosis and management in patients with HIV disease. In: HIV clinical management, vol 6. Medscape, HillsboroGoogle Scholar
  104. Priem S, Franz J, Krause A (1999) Ätiologie und Pathogenese bakteriell bedingter Arthritiden. Infektiöse Arthritis, reaktive Arthritis, Lyme-Arthritis. Internist 40: 936–944Google Scholar
  105. Raad I (1998) Intravascular catheter related infections. Lancet 351: 893–898PubMedGoogle Scholar
  106. Richards MJ, Edwards JR, Culver DH, Gaynes RP (1999) Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System. Crit Care Med 27: 887–892PubMedGoogle Scholar
  107. Robert-Koch-Institut. HIV/AIDS-Bericht II/2000. Epidemiologisches Bulletin, Sonderausgabe A/2001Google Scholar
  108. Sander A, Kalibe T, Bredt W (1996) Bartonella (Rochalimaea)-Infektionen: Katzenkratzkrankheit und bazilläre Angiomatose. Dtsch Med Wochenschr 121: 65–69PubMedGoogle Scholar
  109. Schmidt KL (Hrsg) (2000) Checkliste Rheumatologie. Thieme, Stuttgart New YorkGoogle Scholar
  110. Schöffel U, Häring R, Farthmann EH (1993) Diagnose und Behandlungsstrategie intraabdomineller Abszesse. Zentralbl Chir 118: 303–308PubMedGoogle Scholar
  111. Schölmerich J, Gerbes AL, Andus T, Leser HG (1995) Spontane bakterielle Peritonitis bei Leberzirrhose mit Aszites. Dtsch Med Wochenschr 120: 454–461PubMedGoogle Scholar
  112. Schultheis KH, Rehm KE, Ecke H (Hrsg) (1991) Chirurgische Infektionen von Knochen, Gelenken und Weichteilen. De Gruyter, Berlin New YorkGoogle Scholar
  113. Seuffer RH (1999) German-Austrian recommendations for post-exposure prophylaxis after HIV infection. Dtsch Med Wochenschr 124 (12): 373PubMedGoogle Scholar
  114. Simon C, Stille W (1999) Antibiotika-Therapie in Klinik und Praxis, 10. Aufl. Schattauer, StuttgartGoogle Scholar
  115. Skidmore SJ, Zuckermann M, Parry JV (2000) Accuracy of plasma HIV RNA quantification: A multicenter study of variability. J Med Virol 61: 187–194Google Scholar
  116. Small PM, Fujiwara PI (2001) Management of tuberculosis in the United States. N Engl J Med 345: 189–200PubMedGoogle Scholar
  117. Smith JW, Hasan MS (2000) Infectious Arthritis. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas and Bennett’s principles and practice of infectious diseases, 5th edn. Churchill Livingstone, Philadelphia, 1175–1182Google Scholar
  118. Soriano V, Dona C, Rodriguez-Rosado R, Barreiro P, GonzalezLahoz J (2000) Discontinuation of secondary prophylaxis for opportunistic infections in HIV-infected patients receiving highly active antiretroviral therapy. AIDS 14 (4): 383–386PubMedGoogle Scholar
  119. Steere AC (2001) Lyme Disease. N Engl J Med 345: 115–125Google Scholar
  120. Swartz MN (2000) Myositis. In: Mandell GL, Bennett JE, Dolin R (eds) Mandell, Douglas and Bennett’s principles and practice of infectious diseases, 5th edn. Churchill Livingstone, Philadelphia, 1058–1066Google Scholar
  121. The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342: 1301–1308Google Scholar
  122. Tsiodras S, Mantzoros C, Hammer S, Samore M. (2000) Effects of protease inhibitors on hyperglycemia, hyperlipidemia, and lipodystrophy: A 5-year cohort study. Arch Intern Med 160 (13): 2050–2056PubMedGoogle Scholar
  123. Vanhems P et al. (2000) Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS. J Infect Dis 182 (1): 334–337PubMedGoogle Scholar
  124. Warren JW (1997) Catheter-associated urinary tract infection. Infect Dis Clin North Am 11: 609–620PubMedGoogle Scholar
  125. Weinstein MC, Goldie SJ, Losina E et al. (2001) Use of genotypic resistance testing to guide hiv therapy: clinical impact and cost-effectiveness. Ann Intern Med 134 (6): 440–450PubMedGoogle Scholar
  126. Wettstein M, Kudlek C, Häussinger D (2000) Spontan bakterielle Peritonitis. Diagnose, Therapie and Prophylaxe. Dtsch Ärztebl 47: B 2370–2373Google Scholar
  127. WHO (1995) Drugs used in parasitic diseases. GenfGoogle Scholar
  128. Winkeltau GJ (1995) Die diffuse Peritonitis. Grundlagen and Konzepte far eine differenzierte Therapie: Wissenschaftliche Verlagsgesellschaft, StuttgartGoogle Scholar
  129. Wittmann D (1996) Duration of antibiotic treatment in surgical infection of the abdomen. Eur J Surg (Suppl): 19–23Google Scholar
  130. Zala C, Rouleau D, Montaner JSG (2000) Role of hydroxyurea in treatment of disease due to human immunodeficiency virus infection. Clin Infect Dis 30: S143–5150PubMedGoogle Scholar
  131. Zaleznik DF, Kasper DL (1998) Intraabdominal infections and abscesses. In: Fauci AS, Braunwald E, Isselbacher KJ et al. (eds) Harrison’s principles of internal medicine. McGraw-Hill, New York, pp 792–796Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2003

Authors and Affiliations

  • Norbert Suttorp
  • Martin Mielke
  • Henning Breithaupt
  • Frank Bergmann
  • Ulrich Bienzle
  • Friedrich Grimminger
  • Jürgen Lohmeyer
  • Werner Seeger
  • Hans-Dieter Walmrath
  • Dirk Schürmann

There are no affiliations available

Personalised recommendations